Update - @clairblacketer will give us an overview of CDMv6.0
Presentation - @Patrick_Ryan will present on Applying OHDSI tools for large-scale analysis for comparative effectiveness: Clinical use case for Type 2 diabetes treatments
They certainly give very strange names to diseases.
Plato
UPCOMING COLLABORATION OPPORTUNITIES
Upcoming Grant Deadlines Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Optional)
Application Deadline: October 4th
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Application Deadline: October 5th
The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
Application Deadline: November 7th
Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Application Deadline: November 16th
LOI due 30 days prior to the application due date
Upcoming Conferences Machine Leanring in Healthcare - August 17-18th in Stanford CA http://mucmd.org/
2018 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop - September 12-14th in Washington DC
The International Society for Quality in Health Care - International Conference - September 23-26th in Kuala Lumpur, Malaysia https://isqua.org/Events/malaysia-2018
International Semantic Web Conference - October 8-12th in Monterey, CA
I could not join the call yesterday but was able to watch the recording during my flight and I must say this was time well spend. I could not resist to post a reply…
@Patrick_Ryan i really enjoyed your presentation and I think we should not under estimate how unique the followed approach is: sharing all results in an interactive way should become the new standard. I therefore think that this study needs a bigger stage, it is really crazy that this study was presented only as a poster presentation. It is a great example on how we in OHDSI define transparent and reproducible research.
I would therefore like to make others, including European regulators, aware of this study and the power the CDM and all the great opportunities the framework and tools have to offer. I was wondering should we not push some great talks, like this one from Patrick, to the YouTube channel (or maybe all Tuesday meetings)? I know we have the Webex but that requires a tool to run etc etc. I also think we should be more proud on our website etc (the American way ).
Some other thoughts:
Do we foresee a future where others can upload the results of for example this study so we take this one step further: really dynamic up-to-date study results? In the PLP group we are working on this idea for prediction and especially external validation, but will we make this the standard for the future?
I saw in the presentation the (to me) cryptic name of the repository and shinyApp link. I am sure there is logic in this name, drug-comparator-outcome, something like that? Are we thinking of standardising this or do we actually prefer “Observe4D” in this case?
I also like the idea of @jon_duke to add annotation and discussion to make it even more interactive and dynamic. Not sure this can be done in Shiny but maybe embedded in another web-page with some threading functionality as seen for new articles etc.
@clairblacketer great work on how you are managing the CDM v6!